The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$6M | 5 mos ago

About Future Fertility

Future Fertility is a Medical AI company focused on reproductive medicine. It is based in Toronto, Canada. Future Fertility applies machine learning inside the IVF lab to improve diagnostics and optimize outcomes. Using its patented Artificial Intelligence machine, the 'Violet,' the company is able to instantaneously analyze the quality of an egg based on a single image. Its diagnostic and predictive tool is for women undergoing both social egg freezing and IVF.

Future Fertility Headquarter Location

73 Richmond Street West Suite 502

Toronto, Ontario, M5H 4E8,



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Future Fertility

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Future Fertility in 1 CB Insights research brief, most recently on May 11, 2022.

Expert Collections containing Future Fertility

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Future Fertility is included in 3 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

1,459 items

Startups focused on providing products and services catering to women's health and wellbeing.


Artificial Intelligence

8,694 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Digital Health

12,795 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Future Fertility News

Future Fertility Announces New CEO

May 2, 2022

May 02, 2022 08:00 AM Eastern Daylight Time TORONTO--( BUSINESS WIRE )-- Future Fertility , a fertility technology company developing AI-enabled and non-invasive solutions to optimize clinical decision making for fertility specialists, today announced that Christine Prada has been named as Chief Executive Officer. Her employment with Future Fertility will commence in early May. Prada joins Future Fertility as a tenured executive in the healthcare and healthcare technology industry with a strong reputation as a versatile, results-focused leader with a growth mindset. Prada spent the past five years building and leading business development at Maple Corporation, a leading Canadian virtual care company. Prada joined as Maple’s third employee, and built, scaled, and accelerated the growth of Maple’s corporate and public sector businesses, which eventually helped the company to raise a CAD$75M investment by Shoppers Drug Mart. Prior to Maple, Prada worked in KPMG’s health and life science commercial strategy practice, providing strategic advice and leading the execution of critical health transformation projects for key government and private sector clients. Prada succeeds Diana Olusanmi, a well-respected technology industry leader who has served Future Fertility as CEO over the past two years. Olusanmi is an early investor in Future Fertility and took on the role of CEO in early 2020. She was instrumental in bringing the company’s first product – Violet™, a non-invasive tool that assesses viability of eggs for fertilization – to market. Olusanmi has also been crucial in raising funding for the business, most recently working to secure a US$6M investment round led by Whitecap Venture Partners and M Ventures. She also built the foundation for a strong operational structure to drive global growth. “On behalf of the whole team, I want to thank Diana for being an advisor to the company since its beginnings and her leadership as CEO,” said Dr. Dan Nayot, co-founder and CMO at Future Fertility. “The strong foundation Diana and team have put in place sets Future Fertility up for an exciting next stage of growth. We are very grateful to her for stepping in at a crucial time and thank her for her service.” “Christy’s experience building sales teams and partnerships in the healthcare technology space is exactly what we need to help take this business to the next level. I feel excited and reassured to pass on the leadership of Future Fertility to Christy’s capable hands,” said Olusanmi. “I am thrilled to be joining Future Fertility at such a pivotal time and look forward to helping the team take the product to the next level of growth globally,” said Prada. “With a success rate of only around 30%, the IVF process is ripe for innovation and provides a perfect opportunity for AI tools to improve outcomes. Dr. Dan Nayot, Alex Krivoi, and the whole Future Fertility team have uncovered an important niche in the process, filling a critical gap in a fast-growing global market. I believe Future Fertility’s technology has the power to help millions of families around the world improve their chances of successful reproduction, reducing emotional and financial stress through the process.” Prada holds a BMOS Degree from the University of Western Ontario, and an MBA from the University of Toronto’s Rotman School of Management. She is also an active proponent of female entrepreneurship, investing in early-stage, women-led/backed companies via her role as a General Partner at the Women’s Equity Lab. About Future Fertility Future Fertility is an innovation-focused fertility technology company developing non-invasive AI-enabled fertility solutions to improve clinical decision making in fertility care and in vitro fertilization (IVF). Our mission is to harness the power of AI to improve fertility care and IVF outcomes, lower costs, and alleviate emotional stress of the patient journey. We’ve developed the first Artificial Intelligence image analysis tool to non-invasively evaluate oocytes (eggs), creating the only objective classification and prediction tool, Violet™, for an oocyte. Beyond our flagship egg prediction software product, Future Fertility has additional AI solutions in its pipeline, unlocking key decision points in IVF cycles. For additional information, visit . Contacts

Future Fertility Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Future Fertility Rank

  • When was Future Fertility founded?

    Future Fertility was founded in 2018.

  • Where is Future Fertility's headquarters?

    Future Fertility's headquarters is located at 73 Richmond Street West, Toronto.

  • What is Future Fertility's latest funding round?

    Future Fertility's latest funding round is Series A.

  • How much did Future Fertility raise?

    Future Fertility raised a total of $6M.

  • Who are the investors of Future Fertility?

    Investors of Future Fertility include Whitecap Venture Partners and M Ventures.

  • Who are Future Fertility's competitors?

    Competitors of Future Fertility include and 1 more.

You May Also Like

ImVitro Logo

ImVitro is a life science company that uses AI to facilitate in vitro fertilization (IVF). The company's B2B SaaS platform helps embryologists better evaluate the videos of developing embryos in the lab, predict which embryo has the highest chance of leading to a pregnancy and a birth, and minimize the number of IVF cycles patients go through.

Life Whisperer

Life Whisperer uses artificial intelligence (AI) to help identify healthy embryos for IVF and improve outcomes for couples wanting to have children. Logo is a clinician-led, healthcare artificial intelligence (AI) company developing and deploying AI-as-medical-device solutions to address persistent healthcare challenges. The company's mission is to carefully develop clinical-grade AI software and make high-quality healthcare available and affordable to every patient, especially those in remote and low-resource settings.

Verily Life Sciences Logo
Verily Life Sciences

Verily Life Sciences develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. The company partners with leading life sciences, medical device and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances, and deployment at scale.

Nanox Logo

Nanox is developing the next generation of X-ray emitters based on groundbreaking nanotechnology. Nanox emitters will finally bring X-ray imaging into the digital era, enabling novel 3D imaging systems with unmatched performance.

DeepMind Technologies

DeepMind is a cutting edge artificial intelligence company. The company combines the best techniques from machine learning and systems neuroscience to build powerful general-purpose learning algorithms.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.